Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer.

Biot C, Rentsch CA, Gsponer JR, Birkhäuser FD, Jusforgues-Saklani H, Lemaître F, Auriau C, Bachmann A, Bousso P, Demangel C, Peduto L, Thalmann GN, Albert ML.

Sci Transl Med. 2012 Jun 6;4(137):137ra72. doi: 10.1126/scitranslmed.3003586.

2.

Immunization route dictates cross-priming efficiency and impacts the optimal timing of adjuvant delivery.

Bouvier I, Jusforgues-Saklani H, Lim A, Lemaître F, Lemercier B, Auriau C, Nicola MA, Leroy S, Law HK, Bandeira A, Moon JJ, Bousso P, Albert ML.

Front Immunol. 2011 Dec 8;2:71. doi: 10.3389/fimmu.2011.00071. eCollection 2011.

Supplemental Content

Loading ...
Support Center